August 10, 2026 06:05 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute | 'They don't need Mohan Bhagwat's certificate': Priyanka Gandhi Vadra's sharp reply to RSS chief's Gen Z remark | 'Students, Gen Z, ask me anything': Rahul Gandhi launches Instagram Q&A, responds to Jharkhand protest | PM Modi goes Gen Z, urges Indians to share 'Get Ready With Me' videos on National Handloom Day | Former Tehelka editor Tarun Tejpal sentenced to 10-year jail term in 2013 rape case as Bombay HC overturns acquittal
Omicron
wallpaper cave

UK approves first Covid booster vaccine targeting Omicron variants

| @indiablooms | Aug 16, 2022, at 12:34 am

London: The UK Medicines and Healthcare products Regulatory Agency said on Monday that it has approved the first COVID-19 booster vaccine developed by US-based pharmaceutical company Moderna that targets original and Omicron strains.

"An updated version of the COVID-19 vaccine made by Moderna that targets two coronavirus variants (known as a 'bivalent' vaccine) has today been approved for adult booster doses by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness," the agency said.

The name of the vaccine is Spikevax bivalent Original/Omicron. MHRA said that each dose contains 25 micrograms of Omicron vaccine and 25 micrograms of original coronavirus vaccine, which targets the strain from 2020.

The vaccine triggers a strong immune response against both strains, as well as a good immune response against sub-variants of Omicron, the agency said, adding that patients experience the same side effects as from the original Moderna booster dose.

The vaccine has been granted a conditional marketing authorization in England, Scotland and Wales, and an emergency use authorization in Northern Ireland.

MHRA Chief Executive June Raine said in the statement that the new vaccine provides "a sharpened tool in our armoury to help protect us against this disease" while the first generation of COVID-19 vaccines "continue to provide important protection."

According to UK broadcaster Sky News, the new booster vaccine has also been submitted for approval in Australia, Canada, and the European Union.

 

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.